Clinical trial

Treating Binge Eating and Obesity Digitally in Women

Opening soon · Not applicable · 1 countries · Registry ID NCT05693896

Opening soonNot applicableInterventional

What this study is about

More than 30% of Black women with obesity binge eat. Binge eating may increase the risk for the development of metabolic syndrome and binge-eating-disorder (BED), which is associated with severe obesity. Though several effective treatments for binge eating exist, Black women have not fared well. Not only has their inclusion in treatment trials been limited, but when participating, they are more likely to drop out, and/or lose less weight, compared to their White counterparts. Furthermore, treatment for binge eating is often not available in primary care and community-based settings places where Black women are more likely to receive treatment for their eating and weight-related concerns. Currently, there is scant intervention research to treat binge eating in Black women. With the highest rates of obesity (57%) nationally, Black women are in need of culturally-relevant treatments for binge eating and weight gain prevention. Given the established relationship between frequent binge eating and subsequent weight gain, addressing binge eating among Black women with obesity is imperative.

A promising-looking record is not the same as confirmed eligibility. The study team must review the full criteria and current recruitment status.

Basic eligibility

Age18 Years to Not listed

SexFemale

Healthy volunteersAccepted

ConditionBinge Eating, Binge-Eating Disorder, Weight Gain Prevention, Obesity

Full registry criteria

Inclusion Criteria: * Over 18 years of age with pre-diabetes, * Have an (A1c between 5.7%-6.4%), * BMI ≥ 30 kg/m\^2, * have and regularly use a Bluetooth-enabled smartphone, * report at least one binge eating episode weekly, * work or live within 30 miles of Kannapolis, NC, * Have not used prescription weight loss medications (like Wegovy, Zepbound, or Ozempic) in the past 3 months Exclusion Criteria: * currently pregnant, * Are currently taking or have taken within the prior 3 months (12 weeks) a GLP-1, * in substance abuse treatment, * involved in another weight reduction program, * have a history of anorexia, * are purging, * currently in treatment for eating difficulties, * are concurrent intravenous drug users * consume \>4 alcoholic beverages/day

Treatments and study arms

Centering Appetite

Behavioral

A digital treatment of Appetite Awareness Treatment (AAT) and behavioral weight loss treatment (BWL) over 6 months, delivered remotely using Zoom. The goal of AAT is to enable participants to be able to relearn their stomach's hunger signals and begin to obey and monitor functions of satiety. AAT has been successful in helping participants diagnosed with Binge Eating Disorder (BED) and bulimia nervosa reduce binge eating, overeating, urges to eat in response to non-appetite stimuli, and prevent weight gain.

Primary outcomes

Feasibility (Recruitment): Total Number of Eligible Adults Enrolled in the Study4 month

Recruitment is defined as the number of potential eligible adults screened for the study versus the number of persons who enrolled in the study.

Retention: Percentage of Participants Retained in the Study6 months

Percentage of eligible participants who were enrolled and retained in the study through the 6 months.

Attendance: Percentage of Intervention Sessions Attended6 months

Percentage of intervention sessions attended for the duration of the study by each participant.

Study locations

1 locations were listed when this page was built. The first 40 are shown.

UNC-Chapel Hill🇺🇸 Chapel Hill, North Carolina, United States

Open map

Rachel Goode, PhD,MPHContact